1. |
Sahn SA. Corticosteroids in chronic bronchitis and pulmonary emphysema.Chest. 1978 Mar;73(3):389-96.
|
2. |
van Grunsven PM, van Schayck CP, Derenne JP, et al.Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Thorax. 1999 Jan;54(1):7-14.
|
3. |
Vestbo J, Sørensen T, Lange P, et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial.Lancet. 1999;353(9167):1819-23.
|
4. |
Pauwels RA, Löfdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.N Engl J Med. 1999 ;340(25):1948-53.
|
5. |
The Lung Health Study Research Group.Effect of Inhaled Triamcinolone on the Decline in Pulmonary Function in Chronic Obstructive Pulmonary Disease. N Engl J Med 2000;343: 1902–1909.
|
6. |
Burge PS, Calverley PM, Jones PW et al.Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000 ;13;320(7245):1297-303.
|
7. |
Hattotuwa KL, Gizycki MJ, Ansari TW, et al.The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Am J Respir Crit Care Med. 2002;165(12):1592-6.
|
8. |
Culpitt SV, Maziak W, Loukidis S, et al.Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1635-9.
|
9. |
Calverley P, Pauwels R, Vestboet J , et al.Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003, 361: 449–56.
|
10. |
Calverley PM, Anderson JA, Celli B,et al, Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease. N Engl J Med 2007;356:775-89.
|
11. |
Celli BR, Thomas NE, Anderson JA, et al. Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease.Results from the TORCH Study. Am J Respir Crit Care Med. 2008 Aug 15;178(4):332-8.
|
12. |
Barnes NC, Qiu YS, Pavord ID, et al .Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.Am J Respir Crit Care Med. 2006 Apr 1;173(7):736-43.
|
13. |
Bourbeau J, Christodoulopoulos P, Maltais F, et al..Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. Thorax. 2007;62(11):938-43.
|
14. |
Perng DW, Tao CW, Su KC, et al. Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD. Eur Respir J. 2009;33(4):778-84.
|
15. |
Cazzola M, Di Lorenzo G, Di Perna F, et al.Additive effects of salmeterol and fluticasone or theophylline in COPD.Chest. 2000 Dec;118(6):1576-81.
|
16. |
Tashkin DP, Rennard SI, Martin P, et al.. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial. Drugs. 2008;68(14):1975-2000.
|
17. |
Szafranski W, Cukier A, Ramirez A, et al.Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J. 2003;21(1):74-81.
|
18. |
Hanania NA, Darken P, Horstman D, et al. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.Chest. 2003 Sep;124(3):834-43.
|
19. |
Mortaz E, Rad MV, Johnson M, et al.Salmeterol with fluticasone enhances the suppression of IL-8 release and increases the translocation of glucocorticoid receptor by human neutrophils stimulated with cigarette smoke.J Mol Med. 2008 ;86(9):1045-56.
|
20. |
Sarir H, Mortaz E, Karimi K, et al.Combination of fluticasone propionate and salmeterol potentiates the suppression of cigarette smoke-induced IL-8 production by macrophages.Eur J Pharmacol. 2007;571(1):55-61.
|
21. |
Mortaz E, Rad MV, Johnson M, et al.Salmeterol with fluticasone enhances the suppression of IL-8 release and increases the translocation of glucocorticoid receptor by human neutrophils stimulated with cigarette smoke. J Mol Med. 2008 September; 86(9): 1045–1056.
|